Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Fractyl Health (GUTS) Shares Outstanding (Weighted Average) (2023 - 2025)

Fractyl Health's Shares Outstanding (Weighted Average) history spans 3 years, with the latest figure at $75.8 million for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Weighted Average) rose 74.13% year-over-year to $75.8 million, compared with a TTM value of $75.8 million through Dec 2025, up 74.13%, and an annual FY2025 reading of $75.8 million, up 74.13% over the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $75.8 million at Fractyl Health, up from $54.2 million in the prior quarter.
  • The five-year high for Shares Outstanding (Weighted Average) was $75.8 million in Q4 2025, with the low at $2.1 million in Q1 2023.
  • Average Shares Outstanding (Weighted Average) over 3 years is $33.0 million, with a median of $41.2 million recorded in 2024.
  • Year-over-year, Shares Outstanding (Weighted Average) skyrocketed 2212.86% in 2024 and then rose 13.07% in 2025.
  • Tracing GUTS's Shares Outstanding (Weighted Average) over 3 years: stood at $2.1 million in 2023, then soared by 1992.01% to $43.5 million in 2024, then skyrocketed by 74.13% to $75.8 million in 2025.
  • Per Business Quant, the three most recent readings for GUTS's Shares Outstanding (Weighted Average) are $75.8 million (Q4 2025), $54.2 million (Q3 2025), and $49.0 million (Q2 2025).